Omers Administration Corp Gilead Sciences, Inc. Transaction History

Omers Administration Corp

$10.4 Billion
Q3 2024

A detailed history of Omers Administration Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Omers Administration Corp holds 69,916 shares of GILD stock, worth $6.39 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

69,916

Previous 70,716 1.13%

Holding current value

$6.39 Million

Previous $4.85 Million 20.8%

% of portfolio

0.06%

Previous 0.05%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $53,272 - $67,192	-800 Reduced 1.13%	69,916 $5.86 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $4.47 Million - $5.15 Million	70,716 New	70,716 $4.85 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $9.06 Million - $9.97 Million	-147,100 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$62.51 - $69.0 $1.92 Million - $2.12 Million	30,700 Added 26.37%	147,100 $9.32 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $5.42 Million - $6.08 Million	87,600 Added 304.17%	116,400 $7.97 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $1.8 Million - $2.02 Million	28,800 New	28,800 $1.94 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $6.01 Million - $7.84 Million	-99,200 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $940,896 - $1.04 Million	13,200 Added 15.35%	99,200 $7.66 Million
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $1.56 Million - $1.82 Million	24,100 Added 38.93%	86,000 $6.09 Million
Q1 2018 May 11, 2018	SELL	$72.84 - $88.8 $298,644 - $364,080	-4,100 Reduced 6.21%	61,900 $4.67 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $2.01 Million - $2.36 Million	28,200 Added 74.6%	66,000 $4.73 Million
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $2.73 Million - $3.23 Million	37,800	37,800 $3.06 Million

Others Institutions Holding GILD

# of Institutions

1,928

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.

Account

Omers Administration Corp Gilead Sciences, Inc. Transaction History